TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Presented positive updated data from the ALLOHA™ Phase 1 heme trial at…
Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026
Company to Host Conference Call at 8:30am ET March 04, 2026 07:00…
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated…
Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results
February 20, 2026 17:16 ET | Source: Constellation Software Inc. TORONTO, Feb.…
GigaCloud Technology Inc to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 26, 2026
February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif.,…
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million…
Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
Mawson Infrastructure Group Inc. Releases Preliminary Unaudited Results for Fourth Quarter and Fiscal Year 2025
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large…
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
February 05, 2026 07:01 ET | Source: BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE…
ChipMOS Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call
February 04, 2026 05:00 ET | Source: ChipMOS TECHNOLOGIES INC. HSINCHU, Taiwan,…
